Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Surfactant and CPAP for RDS in Premature Infants
NCT00005774Phase 3Terminated
- Sponsor
- NICHD Neonatal Research Network
- Start
- May 2000
- Primary completion
- Jul 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of beractant in respiratory distress syndrome (RDS) (2 arms), sponsored by NICHD Neonatal Research Network. Primary endpoint: Need for mechanical ventilation following randomization at 120 days. Started May 2000; status: terminated.
02
Drugs
beractant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT00005774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005774.